583-P: Perspectives on Stringent Glycemic Control and Weight Loss among People with Type 2 Diabetes Mellitus (T2DM) in China

Introduction 6.5% (71.31%). This sample indicated that achieving stringent glycemic control would be extremely (82.83%) or moderately (12.12%) important. Most of the study sample (90.10%) perceived achieving stringent glycemic control could bring positive impact to physical health. More than half of the sample (62.83%) perceived ≥ 10% weight loss as beneficial or neutral. Out of 231 participants who perceived beneficial, 117 (50.65%) and 84 (36.36%) indicated that ≥ 10% weight loss was extremely or moderately important, respectively. Moreover, around 70% of the study sample preferred treatments with higher rates of achieving both stringent glycemic control and weight loss, when safety profiles were similar. Conclusion: This study underscored that the majority of PWD recognized paramount importance of stringent glycemic control and weight loss in China. Their treatment preferences, which reflected their perceptions, may have implications for decision-making of diabetes treatments in clinical practice. Disclosure J. Zhang: None. A. Li: None. J. Quan: None. J. Wu: None. H. Cai: None. Y. Ding: Employee; Eli Lilly and Company. Stock/Shareholder; Eli Lilly and Company. J. Tang: Employee; Lilly Diabetes. X. Ma: Employee; Eli Lilly and Company. J. Zhang: None. Funding Eli Lilly and Company, Shanghai, China